IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Progesterone Receptor Positive
National Cancer Institute (NCI)monoclonal_antibodyPhase 2Dormant
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Progesterone Receptor Positive cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Inno-206 City of Hope Medical Center | Phase 3 | BB |
Letrozole Emory University | Phase 2 | BB |
TRASTUZUMAB M.D. Anderson Cancer Center | Phase 3 | BB |
Cyclophosphamide City of Hope Medical Center | Phase 3 | BB |
FULVESTRANT Emory University | Phase 3 | BB |
View all 32 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →